
Ampoules
Gerresheimer's pharmaceutical ampoules are made with years of expertise and are in demand by customers worldwide.
Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty products made of glass and plastic, the company contributes to health and well-being. Gerresheimer is represented worldwide and produces with around 10,000 employees wherever its customers and markets are.
Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty products made of glass and plastic, the company contributes to health and well-being.
Our portfolio contains a wide range of pharmaceutical packaging and products to ensure the safe, simple administration of medicines. These include insulin pens, inhalers, micro pumps, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure, and safety systems.
Gerresheimer operates 36 plants worldwide to ensure availability wherever our customers and markets are, employing around 10,000 people.
With plants in Europe, North and South America and Asia, Gerresheimer generates sales of around €1.4 billion. Its wide range of products includes ¬pharmaceutical packaging and products for the simple and safe administration of medicines: Insulin pens, inhalers, micropumps, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medications with closure and safety systems as well as packaging for the cosmetics industry.
The Plastics & Devices division’s product portfolio includes complex, customer-specific products for convenient and safe drug delivery, such as insulin pens, inhalers and pre-fillable syringes. Diagnostics and medical technology products ranging from lancing devices and test systems, to plastic packaging for liquid and solid pharmaceuticals with closure and safety systems, are also manufactured by this division.
The Plastics & Devices division is composed of the Medical Plastic Systems, Plastic Packaging and Syringe Systems business units.
Medical Plastic Systems develops complex plastic systems and system components. Gerresheimer designs and manufactures them within the framework of individual projects, mainly for customers in the pharmaceutical, diagnostics and medical technology sectors.
Medical Plastic Systems provides an individual service across all supply chain processes. The medical plastic systems range extends from inhalers for the targeted treatment of respiratory diseases, lancing devices and insulin pen systems for diabetes sufferers to a wide range of test systems and disposable products for laboratory and molecular diagnostics.
Plastic Packaging’s portfolio includes plastic packaging systems for liquid and solid pharmaceuticals. Administration and dosing systems such as eye drop or nasal spray bottles and special containers for tablets and powder are some of the products in our comprehensive range of high quality primary pharmaceutical packaging. Duma® brand multifunctional closures with tamper-evident seals, child-resistant and senior-friendly closures and integrated moisture absorbers are key product features in the Plastic Packaging range.
Syringe Systems supplements the other two business units’ portfolios with pre-fillable plastic and glass syringe systems and the relevant accessories. Our highly specialised expertise and pharma-compliant technologies enable us to offer high quality primary packaging products to our customers in the pharmaceutical and biotech sectors.
We generate most of our syringe system revenues with our leading Gx RTF® (Ready to Fill) brand syringes. These syringes are supplied by us to the pharma industry in a wide range of designs and in a ready-to-fill state after washing, siliconisation, pre-assembly and sterilisation.
The Primary Packaging Glass Division manufactures glass primary packaging products for pharmaceuticals and cosmetics such as pharmaceutical jars, ampoules, vials, cartridges, perfume flacons and cosmetic cream jars, as well as special glass packaging for the food and beverage industry.
Gerresheimer has an extensive range of glass primary packaging products for the pharmaceutical industry. It includes moulded glass products such as vials, dropper and syrup bottles in diverse market and needs-oriented designs.
The company also produces borosilicate tubing as the input material for our high-quality speciality ampoules, vials and cartridges. As a result, Gerresheimer is able to offer an almost fully comprehensive range of transparent and amber glass for pharmaceutical packaging.
The Life Science Research Division produces reusable laboratory glassware for research, development and analytics, such as beakers, Erlenmeyer flasks and measuring cylinders, as well as disposable laboratory products such as culture tubes, pipettes, chromatography vials and other specialty laboratory glassware.
Gerresheimer's pharmaceutical ampoules are made with years of expertise and are in demand by customers worldwide.
Gerresheimer manufactures an extensive range of glass and plastic bottles for the pharmaceutical industry.
Gerresheimer is an approved cartridges manufacturer for numerous applications in the pharmaceutical industry.
Gerresheimer manufactures a comprehensive range of pre-fillable syringes solutions, which can be ordered in bulk and ready-to-use formats.
Gerresheimer offers a complete range of vials from 0.6ml to 50ml in size.
Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers.
During the Covid-19 pandemic, Gerresheimer is focusing on aspects including business continuity, customer demand, and supply chain. In 2019, we paved the way for profitable growth. We are investing and working to grow our innovation pipeline. These efforts continue undiminished.
Gerresheimer is one of the leading specialists for the production of high-quality glass and plastic products for the international pharmaceutical and healthcare industry.
In January 2016, Switzerland-based speciality chemical company Clariant broke ground for its new manufacturing and healthcare packaging plant in Tamil Nadu, India.
MERXIN and Gerresheimer worked successfully together to realize the shortest possible time to market for the MERXIN MRX003 Capsule DPI
21 June 2022Gerresheimer and the Finnish MedTech startup Adamant Health partner up to develop a life-changing solution for millions of people worldwide suffering from Parkinson’s disease. The measuring technology and platform in development will address one of the biggest impediments in treating symptoms of Parkinson’s: determining the optimal time to take symptom suppressing medication.
14 June 2022Container-level traceability from production to point-of-care (PoC)
24 May 2022Gerresheimer has significantly ramped up its glass and plastic production capacities in India. A new modern plant to produce high quality plastic containers and closures was built at the Kosamba site, and glass production received a new state-of-the-art and sustainable furnace technology. Both innovations were ceremonially commissioned by the management on the same day in April.
16 May 2022Which packaging or delivery solution is best suited to the respective active ingredient? In addition to Gerresheimer's experts, the g guide has recently been answering this important question for customers and interested parties. At Pharmapack in Paris on 18 and 19 May, Gerresheimer will demonstrate the g guide for the first time at a trade fair on Stand B60/B64.
11 May 2022Gerresheimer AG is expanding its portfolio of highly-innovative platform technologies for drug delivery. Gerresheimer, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, today announced an investment into US-based Portal Instruments, a developer of a next-generation needle-free drug delivery technology. Together, the partners aim at transforming the administration of injectable medicines and improving the patient’s experience, especially for those with chronic diseases.
9 May 2022First-quarter revenue grew organically by 19.1% Adjusted EBITDA up organically by 10.6% Gerresheimer raises revenue guidance to double-digit growth for 2022
7 April 2022Sustainability and product quality play an important role in this award from the international pharmaceutical company
31 March 2022Gerresheimer ceremoniously took over a new building in Berlin, Ohio. In the future, the square plastic containers of the Duma Twist-Off Q brand with a 40-ml filling volume, child-resistant closure, and desiccant for filling with medications for the North American market will be produced here in a clean room. The new building is Gerresheimer's eighth location in total on American soil and is being built directly next to Gerresheimer's prescription packaging production facility. A major customer of the company has now audited the site for its orders.
23 March 2022Pilot production in series quality at the Peachtree City production plant: Development samples, clinical samples all the way to small series production in every project phase for the company’s American customers
18 March 2022Ueli Utzinger is to become Gerresheimer AG’s new Group Senior Director Communication & Marketing as of December 1, 2021. He succeeds Jens Kürten, who is pursuing new opportunities after 12 years of successful marketing and communication work for the company.
10 March 2022Find the best packaging solution in no time at all: The g guide, Gerresheimer’s brand-new digital product selector, is now available on the Gerresheimer website. The g guide leads users to the ideal solution simply by asking a handful of questions. The new tool is aimed at potential customers in the pharmaceutical, biopharma and veterinary medicine industries.
1 March 2022Gerresheimer has entered into an important agreement involving its Advanced Technologies division. An established US biotech company will rely on Gerresheimer's innovative strength and engineering expertise for the development of a new pump to deliver a leading drug for the treatment of rare diseases via continuous parenteral administration.
22 February 2022Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, is further accelerating its profitable growth. The strategic program of formula G is realigning the business with megatrends such as healthcare, sustainability and biotech. Three years in implementing formula G to foster sustainable profitable growth, Gerresheimer has beaten its revenue guidance in 2021. Last year the company generated EUR 1,497m in core business revenues, achieving a strong organic growth of 7.6%. Core business adjusted EBITDA increased to EUR 324m on a currency-adjusted basis meeting the forecast range.
17 February 2022Gerresheimer is expanding its capacities for glass vials at the Wertheim site and at two further sites in China and the USA. The company is investing in production in Wertheim to increase vials capacity by 150 million vials per year and plans to create 70 new jobs for this purpose. The Federal Ministry of Economy and Climate Action supports the investment within the framework of federal funding of production equipment of borosilicate tubular glass and glass vials for use in vaccine production.
8 February 2022As part of the Sustainability Heroes Conference, the DQS and DGQ honored six companies with the Sustainability Heroes Awards. This year the choice in the category Sustainability Strategy fell on Gerresheimer. The company had applied for this award for the first time with its concept. Now Gerresheimer is one of the six companies selected by the jury from a total of 212 applications.
4 November 2021Nurses are among the occupational groups with the most frequent cuts and puncture wounds. This can lead to infection with dangerous pathogens such as hepatitis B and C viruses or HIV.
4 November 2021With SensAIR, Gerresheimer presents an innovative platform for on-body drug delivery which can deliver drugs of higher viscosity, such as monoclonal antibodies (mAb). The aim is to provide patients with the best possible support in the subcutaneous delivery of large-volume biologics.
20 October 2021Gerresheimer's website is now also available in Chinese. As demand for Gerresheimer's innovative and sustainable packaging solutions and drug delivery devices is also growing significantly in China and the company has six production sites in China, Gerresheimer wants to make it easier for its Chinese customers to access information on cooperation in this way.
4 October 2021Gerresheimer has already been well-positioned in India for several years with Triveni Polymers Pvt Ltd in Kundli.
6 January 2021Biotechnologically manufactured active ingredients demonstrate a series of special features. Some are highly viscous, concentrated and in individual cases, tend to interact with silicone oil or, for example, tungsten residue from syringe production.
1 December 2020One of the most important events for pharmaceutical packaging and drug delivery in Asia is CPhI China. It will take place - LIVE - from 16 to 18 December 2020 in the well-known venue SNIEC Shanghai, at booth N5P21.
16 November 2020Medical technology specialist Gerresheimer is pleased to announce that it is extending its services portfolio in Asia.
28 October 2020Gerresheimer will offer its Gx RTF syringes with SG ITC (Integrated Tip Cap) twist-off closure of the Stevanato Group.
6 October 2020Boehringer Ingelheim commissioned Gerresheimer to develop and produce on a large scale the housing module for the new generation of Respimat® inhalers.
24 September 2020Gerresheimer adds essential laboratory and regulatory services to its broad portfolio of products, solutions and services for biotech companies.
21 September 2020Since 1 June 2020, Gerresheimer has been supplying its plants in Wackersdorf, Pfreimd and Horšovský Týn with electricity which is obtained 100% from renewable energies, with the emphasis on hydroelectric power.
9 July 2020Covid-19 vaccines under development to protect from the disease are, like numerous other drugs, filled in injection or vials comprised of type 1 borosilicate glass.
2 July 2020Hand sanitisers are currently urgently needed everywhere to protect against infection from coronavirus.
11 May 2020The two Gerresheimer production locations of Horšovský Týn and Pfreimd have been awarded gold status for the year 2019 by the customer AstraZeneca.
6 May 2020Gerresheimer Group company Centor Inc has laid the foundations for a brand new warehouse covering a total area of 72,000m2.
27 April 2020Hand sanitiser is currently a scarce commodity. Malteser Hilfsdienst, a German aid organisation is now feeling the effect of this, as are many other health care facilities.
6 April 2020As a leading specialist in drug packaging and administration, Gerresheimer has been a part of Pharmapack for many years.
3 February 2020Gerresheimer Medical Systems, together with US-based Portal Instruments, has manufactured a new primary drug container for use in needle-free automatic injection systems.
21 January 2020As a leading provider of speciality pharmaceutical packaging, Gerresheimer also specialises in manufacturing pharmaceutical containers made from type II glass.
9 January 2020Gerresheimer has been positioned strongly in India for many years through Kundli’s Triveni Polymers Pvt Ltd.
16 December 2019Drugs are not intended to fall into the hands of children. However, in case this ever happens, it is essential to restrict them from being able to open the receptacles by fastening them with child-resistant caps.
26 November 2019The Gx Elite vials and Gx RTF vials will be setting a new standard for type I vials made from borosilicate glass at booth 111B10 at CPhl Worldwide in Frankfurt from 5-7 November.
29 October 2019At FCE Pharma in São Paulo, Gerresheimer will be showcasing a complete solution for packaging effervescent vitamin C tablets, which are currently seeing strong demand.
17 May 2019Gerresheimer has announced it will showcase innovative primary packaging and drug administration systems at CPhl North America.
24 April 2019Gerresheimer will reveal its first snap-on cap with child-resistant (CR) solution at booth B62 at this year's Pharmapack.
31 January 2019Portal Instruments and Gerresheimer have announced they will be presenting a joint presentation titled: 'New Meets Old: Challenges and Solutions with Developing a Custom Primary Container'.
23 January 2019In July of this year, Gerresheimer acquired Sensile Medical, expanding its business model to become an original equipment manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities.
4 December 2018The Gx Elite vials have set new standards for Type 1 borosilicate glass vials. They are the result of comprehensive optimisation measures in the conversion process, which have focused on designing out the risk to create product flaws during production, including the removal of all glass-to-glass or glass-to-metal-contact beginning with the tubing material all the way through final packaging.
10 October 2018Gerresheimer has announced it is expanding its range of services to include surface finishing of plastic packaging for ophthalmology and rhinology products with irradiation.
19 September 2018By acquiring Switzerland-based Sensile Medical in July this year, Gerresheimer is expanding its business model to become an original equipment manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities.
12 September 2018Gerresheimer Gx Solutions is developing packaging solutions for the complex injectable drugs of tomorrow.
30 August 2018Gerresheimer develops and produces innovative drug delivery systems and medical and diagnostic products for prestigious international customers.
15 August 2018With a total of 13 sites across Asia for its range of glass and plastic products, Gerresheimer has announced it will be attending the Medipharm Expo this month.
3 August 2018Gerresheimer has announced it expects increased growth and profitability mid-term due to two new major orders with temporarily higher capital index (capex) / organic revenue guidance 2018 narrowed to the upper end of the range.
12 July 2018Gerresheimer is presenting new products such as the Gx InnoSafe, the metal-free ready-to-fill (RTF) syringe, and RTF vials at the CPhI China trade fair in Shanghai.
19 June 2018Gerresheimer has announced that is has expanded its production capabilities at its plastic primary packaging manufacturing site in Anápolis, Goiás, Brazil.
22 May 2018Gerresheimer’s Indian plants produce glass vials, ampoules and bottles that are specially designed for the storage of high-quality drugs.
17 May 2018Gerresheimer has announced it will be attending CPhI South East Asia, where it will be showcasing a range of innovations and company news, including the opening of its new tubular glass production plant in India for producing MultiShell vials.
26 March 2018Gerresheimer’s booth at the PDA Annual Meeting will focus on innovative glass and plastic vials for parenteral drugs that place high demands on the barrier properties and the safety of their primary packaging.
15 March 2018Gerresheimer offers pharmaceutical and medical technology products of plastics and glass in its medical systems business unit.
8 March 2018The Gx Elite vials are type I vials that meet high standards. Made from borosilicate glass, the vials prevent any glass-to-glass and glass-to-metal contact. The chemical composition of the borosilicate glass is still the same. Gerresheimer will be showcasing its Gx Elite vials at booth 36 at the PDA in Rome on February 27 and 28.
27 February 2018Gerresheimer has announced will be presenting its Duma Standard CR container, which features Handy Cap CR at Pharmapack.
2 February 2018Gerresheimer has announced it will be attending the Pharma Expo Dhaka trade fair in Bangladesh, focusing on pharmaceutical primary packaging made from glass.
31 January 2018Dr Lukas Burkhardt has been appointed to the management board of Gerresheimer effective 1 January.
8 January 2018Gerresheimer will present their passive integrated safety system for avoiding needlestick injuries at Pharmapack in Paris.
13 December 2017Gerresheimer has announced it will be showcasing glass and plastic pharmaceutical packaging products that are Food and Drug Administration (FDA) registered and manufactured to stringent quality standards to the trade public at CPhI in Mumbai, India.
28 November 2017Gerresheimer has announced that production of its US dropper bottles with a fixed TE-ring will be operational in Q3.
14 November 2017Gerresheimer Medical Systems has announced it will be attending the Compamed trade fair in Düsseldorf
9 November 2017Gerresheimer will be presenting its new type 1 borosilicate glass vial, Gx Elite, at CPhI Worldwide.
28 September 2017With their exposed cannulas, used syringes are an omnipresent source of danger in medical practices, labs, or hospitals.
24 September 2017One of the most talked-about highlights from Gerresheimer's LuxePack trade fair showcase is opal glass.
6 September 2017Gerresheimer is pleased to announce it will be showcasing for the first time at this year's the Pack Expo trade fair, which is due to take place from 27-29 September in Las Vegas, Nevada.
3 September 2017Gerresheimer is pleased to announce it will be showcasing its tubular glass packaging at the Pharmed & Healthcare event from 20-23 September in Ho Chi Minh City, Vietnam.
27 August 2017Gerresheimer is delighted to announce it was presented with the Best Supplier Award from its business partner Mäurer & Wirtz last month.
10 July 2017Gerresheimer has released the first eco-friendly plastic containers for pharmaceutical and cosmetic applications, BioPack.
16 March 2016Gerresheimer AG sustained its successful trend through the third quarter of the financial year.
10 February 2016Gerresheimer AG has successfully wrapped up its refinancing with the launch of a debt issue (Schuldschein) for a total amount of €425m.
9 November 2015Temperature peaks in the manufacturing process are the main cause of delamination in tubular glass vials, which was discovered in a long-term study conducted by Gerresheimer AG and the Alfred University in New York.
10 February 2015People who use eye drops know how difficult they are to put in safely without assistance.
9 February 2015Developers at Gerresheimer believe in making good products better, and are presenting an improved Duma Twist-Off container called Duma Twist-Off Advanced for solid pharmaceuticals.
8 February 2015Gerresheimer is one of only a few companies in the world to offer its customers both glass and COP syringes.
20 May 2014Gerresheimer has developed an interface for the integration of glass syringes in autoinjectors. It has now filed a patent application for its Gx G-Fix standard adapter for precise and reliable positioning of syringes.
20 May 2014The first time that most of us see a syringe and needle we are small babies and our mothers have taken us to the doctor to be vaccinated. Yet it is isn't just children who need vaccinations. For some diseases, we have to get vaccinated again as adults because the original vaccinations stop being effective after 20 years or so.
20 May 2014The new Gx MultiShell Plastic Vials overcome the specific limitations of plastic vials and combine superior properties of plastic and glass containers to a high-end container for parenterals.
11 February 2014The American Academy of Ophthalmology endorses the uniform use of a colour-coding system for caps and labels on topical ocular medications. Topical medications are applied locally, for example eye drops and nasal drops.
11 February 2014Glass ampoules are ideal as a packaging for many cosmetic and pharmaceutical products. Gerresheimer incorporates its many years of experience in the meticulous production of ampoules to guarantee that they are safe to use and always in optimum quality.
11 February 2014At this year's INTERPHEX, which will take place 20-22 April at the Jacob K Javits Convention Center in New York, Gerresheimer Plastic Packaging will be exhibiting its range of pharmaceutical plastic packaging products. Gerresheimer specialises in pharmaceutical and healthcare containers
7 April 2010Tubular glass, moulded glass, plastic, intelligent syringe systems, high-quality vials and bottles, smart safety and application solutions: the whole world of pharma packaging was united in the Gerresheimer Group at Pharmtech Moscow, which was held at the Crocus Expo Center 24–27 November 2009. G
14 January 2010The Gerresheimer Group recently expanded its activities in the pharmaceutical plastic business, through two strategically significant investments in the US and Europe. In September 2009 the company almost simultaneously opened a new research and development centre for medical plastic systems in t
7 January 2010Gerresheimer receives the WorldStar for innovative pharma closures New standards for safety and economy Nomination for the President's Award For a highly innovative pharma closure system under the Duma trademark, Gerresheimer after receiving the 2007 German Packaging
8 November 2007Everything from a single source for the pharmaceutics industry: the Gerresheimer Group again consistently builds on this principle in its plastic packaging business. The latest result of this development is a new tamper-evident closure system for tablet containers, which Gerresheimer manufactures
19 October 2006Thank you for submitting the form. Your enquiry will be submitted to the company.
Thank you for subscribing to Pharmaceutical Technology